Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic. (March 2023)

• Record Type: Journal Article
• Authors: Hoff, Emily; Warden, Andrea; Taylor, Ruby; Nijhawan, Ank E.
• Is Part Of: Public health reports. Volume 138:Number 2(2023)
• Page Start: 248
• Page End: 258
• Publication Date: 2023-03
• Subjects: hepatitis C -- incarceration -- jail; Public health -- United States -- Periodicals; 614.0973
• DOI: 10.1177/00333549221076546
• Languages: English
• ISSNs: 0033-3549

Abstract

Objectives: Nearly 1 in 3 people with hepatitis C virus (HCV) infection pass through the criminal justice system annually; the system is a crucial location for HCV screening, education, and linkage to care. We aimed to (1) determine the prevalence and incidence of HCV antibody positivity and (2) evaluate the demographic characteristics of people with HCV in a large urban jail. Methods: We offered universal opt-out HCV testing to any person undergoing a routine blood test at the Dallas County Jail from June 2015 through December 2019 (N = 14 490). We extracted data on demographic characteristics from the electronic medical record and collected data on risk factors from people with HCV antibody positivity. We performed univariate and multivariate analyses. Results: The prevalence of HCV antibody positivity was 16.7%; the incidence was 13.5 cases per 1000 person-years. HCV antibody positivity was significantly associated with older age ( P < .001), female sex ( P = .004), non-Hispanic White race versus non-Hispanic Black race ( P < .001), and being released to prison versus not ( P < .001). Among people born after 1965, those who were HCV antibody–positive were more frequently non-Hispanic White and Hispanic women, whereas among those born in 1965 or before, those who were HCV antibody–positive were more frequently non-Hispanic Black men. Conclusions: The high prevalence and incidence of HCV antibody positivity in a large county jail argue for routine, universal HCV testing and prevention counseling in criminal justice settings. Changing demographic characteristics mirror those of the national injection drug use epidemic and shed insight into designing interventions for risk reduction, education, linkage to care, and treatment.